Inside the Poppi Class Action Settlement
If you want a single, concrete example of where the marketing in this category outran the science, the Poppi class action is the cleanest one on the public record.
In May 2024, a California consumer named Kristin Cobbs filed a class action against Poppi in the U.S. District Court for the Northern District of California. The complaint, formally captioned Cobbs v. Poppi Inc., argued that Poppi's "prebiotic" and "gut healthy" marketing was misleading because a single can contained only about 2 grams of prebiotic fiber — too little, plaintiffs argued, to deliver meaningful gut health benefits from one serving. Coverage by ClassAction.org summarized the central claim plainly: a consumer would have to drink more than four cans per day to approach the dose of prebiotic fiber clinically associated with measurable benefits, and the drink's sugar content would offset much of the upside in the process.
Poppi agreed to settle without admitting wrongdoing, establishing a non-reversionary $8.9 million settlement fund to resolve the claims. On April 14, 2026, U.S. District Judge Haywood S. Gilliam Jr. issued the final approval order, formally closing out the case. Class members who purchased qualifying products during the class period could submit claims for up to about $0.75 per single can and proportionally higher amounts per multi-pack.
Why the Settlement Matters Beyond the Money
There are a few honest ways to read what happened. One is that Poppi got caught overselling a real but modest ingredient. Another is that the case formalized, through the legal system, a tension that registered dietitians and gastroenterologists had been quietly flagging for years: that the dose-response gap between "fiber in this can" and "fiber that does what the label suggests" was wide enough to drive a truck through. Neither reading requires the product to be bad. It just requires the marketing to be honest about what 2 grams of fiber can and can't do on its own.
The broader regulatory backdrop is worth keeping in mind. The FDA authorizes health claims on food packaging only when they meet a high standard of "significant scientific agreement," with qualified health claims allowed when some evidence exists but isn't yet conclusive. As of mid-2026, there is no FDA-authorized disease-risk-reduction claim specific to prebiotic sodas, which is why the language on the cans has gradually shifted from definitive promises toward softer "supports gut health" phrasing.